Induced pluripotent stem cells, the workhorse of many regenerative medicine projects, start out as differentiated cells that are reprogrammed to pluripotent stem cells by exposure to a complex set of genetic cocktails. Mayo researchers now report that using the measles virus vector; they’ve trimmed that multi-vector process with four reprogramming [...]

Regenerative medicine therapies aim to rebuild and restore health to patients challenged by chronic conditions and degenerative diseases. Despite advances in the field, much of the science is still in early research phases, meaning that many treatments haven’t been proven safe and effective for humans as standard-of-care therapies yet. Because [...]

Regenerative Medicine Minnesota is accepting proposals for grants relating to regenerative medicine education programs, clinical care, and biobusiness/biotechnology. Applicants must be based in Minnesota. Important notes for Mayo Clinic investigators: Mayo investigators should work with the Office of Sponsored Projects Administrationto develop a detailed budget prior to submitting a proposal. Contact your sponsored project specialist. Arizona [...]

Regenerative Medicine Minnesota (RMM) recently announced the 2019 Regenerative Medicine Minnesota Research Awards. This year's research grants are aimed at developing better therapies for people with diabetes, cartilage injury, heart disease, cancer, chronic obstructive pulmonary disease, spinal cord injury, neurological disorders, and age-related macular degeneration. The grants are awarded to [...]

Mayo Clinic announced last fall that it received a $10 million grant from The Louis V. Gerstner Jr. Fund at Vanguard Charitable on the recommendation of Louis V. and Robin L. Gerstner. The grant supports five initiatives across Mayo Clinic’s Arizona, Florida and Minnesota sites. Two of the five initiatives funded [...]